SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00073



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00073_TNBC_IFN_negative_rep1 6 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_TNBC_IFN_negative_rep2 6 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_TNBC_IFN_negative_rep3 6 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_TNBC_IFN_negative_rep4 9 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_TNBC_IFN_negative_rep5 9 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_TNBC_IFN_positive_rep4 9 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_MDA_MB231_Rep1_IFN_positive 9 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_MDA_MB231_Rep1_IFN_positive_classII 10 Human DRB1_0701,DRB1_1305,HLA-DPA10201-DPB11701,HLA-DQA10202-DQB10301
SYSMHC00073_MDA_MB231_Rep2_IFN_negative 9 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_MDA_MB231_Rep3_IFN_positive_classII 10 Human DRB1_0701,DRB1_1305,HLA-DPA10201-DPB11701,HLA-DQA10202-DQB10301
SYSMHC00073_MDAMB231_IFN_positive_rep5_Immuno_classI 9 Human HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01
SYSMHC00073_MDAMB231_IFN_positive_rep5_Immuno_classII 10 Human DRB1_0701,DRB1_1305,HLA-DPA10201-DPB11701,HLA-DQA10202-DQB10301



Detailed view of sample SYSMHC00073_MDA_MB231_Rep2_IFN_negative



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool1.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 1
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool2.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 2
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool3.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 3
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool4.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 4
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool5.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 5
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool6.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 6
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool7.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 7
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool8.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 8
SYSMHC00073 SYSMHC00073_MDA_MB231_Rep2_IFN_negative F120190517_PF_MDA_MB231_Rep2_IFN_negative_Rep2pool9.raw Human In vitro Breast MDA-MB-231 cell adherent Breast carcinoma class I HLA-A02:01,HLA-A01:17,HLA-B40:02,HLA-B41:01,HLA-C02:02,HLA-C17:01 PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 9